Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography

被引:12
作者
Disa, Jyoti
Floyd, Latitia E.
Edwards, Richard M.
Douglas, Stephen A.
Aiyar, Nambi V.
机构
[1] GlaxoSmithKline Inc, Dept Vasc Biol & Thrombosis, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
[2] GlaxoSmithKline Inc, Dept Urogenital Biol, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
[3] GlaxoSmithKline Inc, Dept Safety Assessment, King Of Prussia, PA 19406 USA
关键词
urotensin-II; UT; autoradiography;
D O I
10.1016/j.peptides.2005.10.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urotensin-II (U-II), a ligand for the G-protein-coupled receptor UT, has been characterized as the most potent mammalian vasoconstrictor identified to date. Although circulating levels of U-II are altered in lower species (e.g., fish) upon exposure to hypo-osmotic stress, little is known about the actions of this cyclic undecapeptide within the kidney, an organ that plays a pivotal role in the control of cardiovascular homeostasis, influencing both cardiac preload (plasma volume) and after load (peripheral resistance). The present study reports the identification of specific, high affinity [I-125]hU-II binding sites in Sprague-Dawley rat kidney outer medulla by autoradiography and also through membrane radioligand binding (K-d 1.9 +/- 0.9 nM and B-max 408 +/- 47 amol mm(-2) and K-d 1.4 +/- 0.3 nM and B-max 51.3 +/- 7.8 fmol mg(-1) protein, respectively). Differences were observed in the binding characteristics within rat strains. Compared to the Sprague-Dawley, Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rat kidney outer medulla displayed low density < 20 fmol mg(-1) protein and low affinity (> 1 mu M) [I-125]hU-II binding sites. Thus, the relative contribution of specific U-II binding sites to the physiological actions of U-II in the control of cardiorenal homeostasis is worthy of further investigation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1532 / 1537
页数:6
相关论文
共 26 条
[1]   Cloning and pharmacological characterization of the cat urotensin-II receptor (UT) [J].
Aiyar, N ;
Johns, DG ;
Ao, ZH ;
Disa, J ;
Behm, DJ ;
Foley, JJ ;
Buckley, PT ;
Sarau, HM ;
van-der-Keyl, HK ;
Elshourbagy, NA ;
Douglas, SA .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (07) :1069-1079
[2]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[3]   Urotensin II: Ancient hormone with new functions in vertebrate body fluid regulation [J].
Balment, RJ ;
Song, W ;
Ashton, N .
TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY, 2005, 1040 :66-73
[4]  
Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533
[5]   Plasma concentrations of arginine vasotocin and urotensin II are reduced following transfer of the euryhaline flounder (Platichthys flesus) from seawater to fresh water [J].
Bond, H ;
Winter, MJ ;
Warne, JM ;
McCrohan, CR ;
Balment, RJ .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2002, 125 (01) :113-120
[6]   Plasma concentration of urotensin II is raised in hypertension [J].
Cheung, BMY ;
Leung, R ;
Man, YB ;
Wong, LYF .
JOURNAL OF HYPERTENSION, 2004, 22 (07) :1341-1344
[7]   Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt):: First demonstration of a pathophysiological role of the urotensin system [J].
Clozel, M ;
Binkert, C ;
Birker-Robaczewska, M ;
Boukhadra, C ;
Ding, SS ;
Fischli, W ;
Hess, P ;
Mathys, B ;
Morrison, K ;
Müller, C ;
Müller, C ;
Nayler, O ;
Qiu, CB ;
Rey, M ;
Scherz, MW ;
Velker, J ;
Weller, T ;
Xi, JF ;
Ziltener, P .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :204-212
[8]  
COWLEY AW, 1995, HYPERTENSION, V25, P662
[9]   From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function [J].
Douglas, SA ;
Dhanak, D ;
Johns, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (02) :76-85
[10]   Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey [J].
Elshourbagy, NA ;
Douglas, SA ;
Shabon, U ;
Harrison, S ;
Duddy, G ;
Sechler, JL ;
Ao, ZH ;
Maleeff, BE ;
Naselsky, D ;
Disa, J ;
Aiyar, NV .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (01) :9-22